anti-CAIX antibody (Checkpoint)

N/A

Report date: 2025/03/14 18:13:36

Base Information

Drug Nameanti-CAIX antibody (Checkpoint)
Drug Alias Nameanti-CAIX antibody (Dana-Farber)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionCarbonic anhydrase IX inhibitors
TargetsCarbonic anhydrase IX
Therapy Area/IndicationsSolid tumoursCarcinoma, Renal CellNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDana-Farber Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesCheckpoint Therapeutics Inc
Inactive CompaniesDana-Farber Cancer Institute
Active IndicationsSolid tumoursCarcinoma, Renal Cell
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A